Tumor Mutational Burden and PD-L1 Expression in Hematologic Malignancies

被引：1
|
作者：
Thomas, Sean D.
Jeong, Ah-Reum
Sakowski, Patrick J.
Sokol, Ethan S.
Kurzrock, Razelle
Goodman, Aaron M.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-134375
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Tumor Mutational Burden, Immunoscore and PD-L1 Expression in Patients with Epstein-Barr virus-associated Gastric Cancer
    He, Lu
    LABORATORY INVESTIGATION, 2019, 99
  • [32] The impact of genomic mutational status on PD-L1 expression and tumor mutation burden in non-small cell lung cancer
    Zhou, Qing
    Gu, Weiguang
    Fu, WenFan
    Mai, Shijie
    Lin, Daren
    Zhang, Shiyue
    Wang, Wenjing
    Zhang, Peng
    CANCER RESEARCH, 2019, 79 (13)
  • [33] Expression of PD-L1 in EBV-associated malignancies
    Li, Xiaoxu
    Zhang, Wenling
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [34] Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma
    Haddad, Robert, I
    Seiwert, Tanguy Y.
    Chow, Laura Q. M.
    Gupta, Shilpa
    Weiss, Jared
    Gluck, Iris
    Eder, Joseph P.
    Burtness, Barbara
    Tahara, Makoto
    Keam, Bhumsuk
    Kang, Hyunseok
    Muro, Kei
    Albright, Andrew
    Mogg, Robin
    Ayers, Mark
    Huang, Lingkang
    Lunceford, Jared
    Cristescu, Razvan
    Cheng, Jonathan
    Mehra, Ranee
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [35] Comparison of tumor mutational burden and pd-l1 between 2797 primary and metastatic breast cancer samples
    Dawood, S.
    Schuster, K.
    Fedlman, R.
    ANNALS OF ONCOLOGY, 2018, 29 : 117 - 117
  • [36] Dual Checkpoint Blockade in a Neuroendocrine Carcinoma With Dual PD-L1/PD-L2 Amplification and High Tumor Mutational Burden
    Gong, Jun
    Patel, Sandip
    Adashek, Jacob J.
    Frishberg, David
    Guan, Michelle
    Placencio-Hickok, Veronica R.
    Gangi, Alexandra
    Gresham, Gillian
    Tuli, Richard
    Chae, Young K.
    Kurzrock, Razelle
    Hendifar, Andrew E.
    JCO PRECISION ONCOLOGY, 2020, 4 : 514 - 519
  • [37] PD-1/PD-L1 expression and molecular associations in HPB malignancies
    Mody, Kabir
    Feldman, Rebecca
    Reddy, Sandeep K.
    Reynolds, Gina A.
    McMillan, Jessica M.
    Johnson, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [38] PD-L1 Expression Is Significantly Associated with Tumor Mutation Burden and Microsatellite Instability Score
    Cho, Yoon Ah
    Lee, Hyunwoo
    Kim, Deok Geun
    Kim, Hyunjin
    Ha, Sang Yun
    Yoon-La Choi
    Jang, Kee-Taek
    Kim, Kyoung-Mee
    CANCERS, 2021, 13 (18)
  • [39] Profiling of Tumor Mutational Burden (TMB), Microsatellite Instability (MSI), and PD1/PD-L1 Immunohistochemistry (IHC) in Gynecological Tumors
    Elvin, Julia A.
    Goldberg, Michael E.
    Gay, Laurie M.
    Liao, John
    Santin, Alessandro D.
    Suh, James
    Vergilio, Jo-Anne
    Ramkissoon, Shakti H.
    Fabrizio, David
    Frampton, Garrett
    Stephens, Philip
    Ross, Jeffrey
    LABORATORY INVESTIGATION, 2017, 97 : 283A - 283A
  • [40] Survival outcomes according to the tumor mutation burden and PD-L1 expression in hepatobiliary tumors
    Sanchez-Garcia, Jorge
    Lopez-Verdugo, Fidel
    Gagnon, Andrew
    Alonso, Diane
    Fujita, Shiro
    Rodriguez-Davalos, Manuel
    Lewis, Mark Andrew
    Gill, David Michael
    Gilroy, Richard
    Haslem, Derrick S.
    Yeatman, Timothy Joseph
    Krong, Jake
    Dong, Li
    Dow, Sean
    Zendejas-Ruiz, Ivan R.
    Thota, Ramya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345